Pulmatrix, Inc.
NASDAQ: PULM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Peter Ludlum
- Employees
- 2
- Headquarters
- Lexington, United States
- IPO year
- 2014
- Market cap
- $5.6M
- Website
- https://www.pulmatrix.com
Loading PULM…
Loading profile data…Frequently asked questions about PULM
What does Pulmatrix, Inc. (PULM) do?
Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respiratory and other diseases within the United States. Central to their approach is the innovative iSPERSE (inhaled small particles easily respirable and...
Where does PULM trade?
Pulmatrix, Inc. (PULM) trades on the NASDAQ Capital Market.
What sector is PULM in?
Pulmatrix, Inc. (PULM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pulmatrix, Inc.?
Peter Ludlum is the chief executive officer of Pulmatrix, Inc. (PULM).
Where is Pulmatrix, Inc. headquartered?
Pulmatrix, Inc. is headquartered in United States.
Does PULM pay a dividend?
Pulmatrix, Inc. (PULM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PULM go public?
Pulmatrix, Inc. (PULM) completed its initial public offering in 2014.